Central Retinal Vein Occlusion
Links shared publicly online about this topic
New treatment regimen for central retinal vein occlusion
eyedocnews.com — “New study compares use of radial optic neurotomy plus intravitreal steroid injection with other regimens” View full resource at eyedocnews.com
Most Recently Shared on May 13, 2010 at 6:36 pm By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: New Treatment for CRVO Combines Radial Optic Neurotomy and Steroid Injection: By Dr. Randall WongThere ma... http://bit.ly/aphTPQ
Central Retinal Vein Occlusion: eMedicine Ophthalmology
emedicine.medscape.com — “Overview: Central retinal vein occlusion (CRVO) is a common retinal vascular disorder. Clinically, CRVO presents with variable visual loss; the fundus may show retinal hemorrhages, dilated tortuous retinal veins, cotton-wool spots, macular edema, and optic disc edema. ...” View full resource at emedicine.medscape.com
Most Recently Shared on October 3, 2010 at 5:28 pm By:
Intraocular injections of 0.3mg/0.5mg ranibizumab showed improvement in 6mo. visual acuity & macular edema in CRVO: http://bit.ly/bGm7Tu
'Bypass' may lead to vision gains for central retinal vein occlusion patients
sciencedaily.com — “Central retinal vein occlusion (CRVO) affects one to four percent of Americans older than 40 and very often causes severe vision loss, including "legal blindness" (20/200 vision). While current treatments reduce CRVO symptoms such as macular edema-swelling of the center of the eye's light-sensitive retina-none address the underlying problem, the blocked retinal vein. Researchers recently took direct aim at the problem, using lasers to create a "bypass" around the constricted ” View full resource at sciencedaily.com
Most Recently Shared on May 6, 2010 at 5:41 pm By:
'Bypass' may lead to vision gains for central retinal vein occlusion patients: Central retinal vein occlusion (CRV... http://bit.ly/9pu53Z
'Bypass' may lead to vision gains for central retinal vein occlusion patients
sciencedaily.com — “Central retinal vein occlusion (CRVO) affects one to four percent of Americans older than 40 and very often causes severe vision loss, including "legal blindness" (20/200 vision). While current treatments reduce CRVO symptoms such as macular edema-swelling of the center of the eye's light-sensitive retina-none address the underlying problem, the blocked retinal vein. Researchers recently took direct aim at the problem, using lasers to create a "bypass" around the constricted ” View full resource at sciencedaily.com
Most Recently Shared on October 29, 2010 at 3:15 pm By:
Ryo Kubota, MD, PhD Doctor, Surgeon, Ophthalmologist, and Physician
Focus on Your Vision Insight: 'Bypass' may lead to vision gains for central retinal vein occlusion patients: http://ow.ly/1UfzQ
Injectable dissolving implant offers benefit for branch and central retinal vein occlusion
osnsupersite.com — “NEW YORK " A biodegradable implant containing dexamethasone that is injected into the vitreous cavity produces significantly improved vision compared” View full resource at osnsupersite.com
Most Recently Shared on October 7, 2009 at 3:46 pm By:
Retina Congress 2009 Top Story: Injectable dissolving implant offers benefit for branch and central retinal vein occlusion http://ow.ly/taAm
Phase 3 CRUISE study suggests safety, efficacy of VEGF therapy in central retinal vein occlusion
osnsupersite.com — “David M. Brown NEW YORK " Inhibition of VEGF in macular edema secondary to central retinal vein occlusion provides rapid and sustained visual” View full resource at osnsupersite.com
Most Recently Shared on October 5, 2009 at 5:29 pm By:
Retina Congress 2009: Phase 3 CRUISE study suggests safety, efficacy of VEGF therapy in central retinal vein occlusion http://ow.ly/sMOD
FDA approves anti-VEGF for treatment of branch, central retinal vein occlusion
osnsupersite.com — “SOUTH SAN FRANCISCO, Calif. " Following a 6-month priority review, the U.S. Food and Drug Administration has approved ranibizumab for treatment” View full resource at osnsupersite.com
Most Recently Shared on June 23, 2010 at 2:22 pm By:
#FDA approves anti-VEGF for treatment of branch, central retinal vein occlusion: http://ht.ly/22dYb — #Breaking #ophthalmology #news
Regeneron Enrolls First Patient in Study of VEGF Trap-Eye to Treat Central Retinal Vein Occlusion
eyedocnews.com — “Regeneron has announced that the first patient was enrolled in its Phase 3 CRVO program; this triggered a $20 million payment from Bayer.” View full resource at eyedocnews.com
Most Recently Shared on July 31, 2009 at 5:41 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Regeneron Commence Study of VEGF Trap-Eye for CVRO Treatment: By Dr. Dominique Walton BrooksReg.. http://bit.ly/OlnoR
Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Central Retinal Vein Occlusion
eyedocnews.com — “As recently reported in MedPage Today, a study published in the April 2009 issue of The Archives of Ophthalmology, researchers have found that intravitreous” View full resource at eyedocnews.com
Most Recently Shared on May 3, 2009 at 4:47 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Cent.. http://tinyurl.com/dj5bta
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion
medicalnewstoday.com — “Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the Phase 3 GALILEO study in patients” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2011 at 7:05 am By:
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion http://mnt.to/3V7b
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
drugs.com — “TARRYTOWN, N.Y., Dec. 20, 2010 PRNewswire-FirstCall Regeneron Pharmaceuticals, Inc. (Nasdaq REGN) today announced that it will hold a teleconference and webcast” View full resource at drugs.com
Most Recently Shared on December 20, 2010 at 9:07 pm By:
Drugs and Devices OW OW Health
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase... http://bit.ly/gz434x #drug
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
drugs.com — “In Phase 3 study in CRVO, 56 percent of VEGF Trap-Eye patients gained at least 15 letters of vision compared to 12 percent in control group VEGF Trap-Eye patien” View full resource at drugs.com
Most Recently Shared on December 20, 2010 at 3:01 pm By:
Drugs and Devices OW OW Health
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occ... http://bit.ly/gsAHQw #drug
aspirin contraindicated in retinal vein occlusion
eyedocnews.com — “aspirin and plavix made the vision worse in central retinal vein occlusions” View full resource at eyedocnews.com
Most Recently Shared on August 30, 2011 at 10:05 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Aspirin Contraindicated in Central Retinal Vein Occlusion: Ophthalmology: Here’s an interesting, counte... http://t.co/Qe6W2fI
lucentis helpful in central vein occlusion
eyedocnews.com — “lucentis proven to improve vision in crvo” View full resource at eyedocnews.com
Most Recently Shared on September 19, 2010 at 5:28 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Lucentis Helps in Central Retinal Vein Occlusion: By Dr. Ari WeitznerAn article in AJO demonstrates concl... http://bit.ly/a0IO8d
Retinal Vein Occlusion
my.clevelandclinic.org — “Retinal Vein Occlusion” View full resource at my.clevelandclinic.org
Most Recently Shared on May 5, 2010 at 3:45 pm By:
Ryo Kubota, MD, PhD Doctor, Surgeon, Ophthalmologist, and Physician
Focus on Your Vision Insight: Understanding retinal vein occlusion, or “eye stroke.†http://ow.ly/14idx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Dr. Ari Weitzner
Brooklyn, NY Ophthalmologist; Editor of EyeDocNews; Founder of Share Medical Space
-
Medscape Ophtha
Latest medical news, articles, and features from Medscape Ophthalmology.
-
sciencedaily
Visit ScienceDaily to read breaking news about the latest discoveries in science, health, the environment, and technology.
Advertisement
